Published in Int J Chron Obstruct Pulmon Dis on May 26, 2011
Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med (2012) 1.52
COPD management: role of symptom assessment in routine clinical practice. Int J Chron Obstruct Pulmon Dis (2013) 1.09
Assessment of COPD wellness tools for use in primary care: an IPCRG initiative. Int J Chron Obstruct Pulmon Dis (2012) 1.04
Evolution of the COPD Assessment Test score during chronic obstructive pulmonary disease exacerbations: determinants and prognostic value. Can Respir J (2013) 0.91
Utility of brief questionnaires of health-related quality of life (Airways Questionnaire 20 and Clinical COPD Questionnaire) to predict exacerbations in patients with asthma and COPD. Health Qual Life Outcomes (2013) 0.80
Behavioral medicine approaches to chronic obstructive pulmonary disease. Ann Behav Med (2012) 0.80
Portuguese-language version of the COPD Assessment Test: validation for use in Brazil. J Bras Pneumol (2013) 0.77
Investigating sensitivity, specificity, and area under the curve of the Clinical COPD Questionnaire, COPD Assessment Test, and Modified Medical Research Council scale according to GOLD using St George's Respiratory Questionnaire cutoff 25 (and 20) as reference. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2014) 0.75
Enhancing the use of Asthma and COPD Assessment Tools in Balearic Primary Care (ACATIB): a region-wide cluster-controlled implementation trial. NPJ Prim Care Respir Med (2016) 0.75
Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients' perceived onset of effect. Int J Chron Obstruct Pulmon Dis (2014) 0.75
Evaluation of the Persian Transcript of the COPD Assessment Test in the Measurement of COPD Health Status in Iranian COPD Patients. Glob J Health Sci (2015) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract (1999) 16.57
Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med (2010) 15.07
The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J (1959) 12.70
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007) 10.12
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax (1999) 8.63
Development and first validation of the COPD Assessment Test. Eur Respir J (2009) 8.06
Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. MMWR Surveill Summ (2002) 7.07
Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes (2003) 4.41
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J (2002) 4.01
Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med (2000) 3.79
Health status measurement in chronic obstructive pulmonary disease. Thorax (2001) 3.07
Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 2.63
Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J (2005) 2.51
Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med (1997) 2.45
Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med (2002) 2.41
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res (2009) 2.31
Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med (2009) 2.17
Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax (2003) 2.11
Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med (2007) 2.06
Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res (2006) 2.03
Quality of life: patients and doctors don't always agree: a meta-analysis. J Clin Epidemiol (2004) 1.86
Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Chest (2006) 1.84
Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med (2010) 1.65
Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis (2008) 1.63
Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study. COPD (2007) 1.58
Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med (2007) 1.51
Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes (2006) 1.49
Validation of the clinical COPD Questionnaire (CCQ) in primary care. Health Qual Life Outcomes (2009) 1.43
The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest (2007) 1.41
Promoting effective self-management programmes to improve COPD. Eur Respir J (2009) 1.39
The Prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population-based study. COPD (2008) 1.28
Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med (2006) 1.18
Measuring the effects of COPD on the patient. Respir Med (2005) 1.13
Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease. Respiration (2003) 1.10
Validation of the Clinical COPD questionnaire in Italian language. Health Qual Life Outcomes (2005) 1.08
Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. Am J Med (2006) 1.05
Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med (2009) 1.00
Measuring patient and clinician perspectives to evaluate change in health-related quality of life among patients with chronic obstructive pulmonary disease. J Gen Intern Med (2007) 0.95
Exacerbations of chronic obstructive pulmonary disease--a patients' perspective. Prim Care Respir J (2006) 0.94
Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study. Int J Tuberc Lung Dis (2008) 0.93
Health status: what does it mean for payers and patients? Proc Am Thorac Soc (2006) 0.92
How are you doing? What are you doing? Differing perspectives in the assessment of individuals with COPD. COPD (2007) 0.91
Factors determining the quality of life of patients with COPD in primary care. Ther Adv Respir Dis (2007) 0.88
Disability in COPD and its relationship to clinical and patient-reported outcomes. Curr Med Res Opin (2011) 0.86
Seattle Obstructive Lung Disease Questionnaire: sensitivity to outcomes in pulmonary rehabilitation in severe pulmonary illness. J Cardiopulm Rehabil (2005) 0.84
The impact of change in exercise tolerance on activities of daily living and quality of life in COPD: a patient's perspective. COPD (2007) 0.77
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother (2005) 7.42
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology (2012) 4.83
European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl (2012) 3.98
Privatising primary care. Br J Gen Pract (2006) 3.68
The public health implications of world trade negotiations on the general agreement on trade in services and public services. Lancet (2003) 3.52
The future of peptide-based drugs. Chem Biol Drug Des (2013) 3.41
Accessibility, acceptability, and effectiveness in primary care of routine telephone review of asthma: pragmatic, randomised controlled trial. BMJ (2003) 2.93
Antibiotic prescribing and outcomes of lower respiratory tract infection in UK primary care. Chest (2009) 2.35
Family medicine in 2018. Can Fam Physician (2010) 2.24
Symptom-based questionnaire for identifying COPD in smokers. Respiration (2005) 2.18
Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med (2009) 2.17
Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med (2006) 2.10
Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med (2006) 2.08
Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J (2011) 2.08
COPD screening efforts in primary care: what is the yield? Prim Care Respir J (2007) 2.03
Screening for and early detection of chronic obstructive pulmonary disease. Lancet (2009) 1.99
No evidence that patient choice in the NHS saves lives. Lancet (2011) 1.96
Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol (2004) 1.88
Clinical and cost effectiveness of mobile phone supported self monitoring of asthma: multicentre randomised controlled trial. BMJ (2012) 1.87
Role of living liver donation in the United Kingdom. BMJ (2003) 1.82
The impact of asthma and COPD in sub-Saharan Africa. Prim Care Respir J (2011) 1.81
General practitioners with a special clinical interest: a model for improving respiratory disease management. Br J Gen Pract (2002) 1.80
The International Primary Care Respiratory Group (IPCRG) Research Needs Statement 2010. Prim Care Respir J (2010) 1.76
High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study. J Allergy Clin Immunol (2008) 1.76
The market in primary care. BMJ (2007) 1.73
Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol (2009) 1.70
Do people self-reporting information about chronic respiratory disease have corroborative evidence in their general practice medical records? A study of intermethod reliability. Prim Care Respir J (2007) 1.67
Not all asthma inhalers are the same: factors to consider when prescribing an inhaler. Prim Care Respir J (2009) 1.66
The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Respir J (2009) 1.64
A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system. Diabetes Technol Ther (2013) 1.61
Achieving asthma control in practice: understanding the reasons for poor control. Respir Med (2008) 1.61
Clinical trials and tribulations: the MASCOT study. Thorax (2011) 1.59
Impact of chronic respiratory symptoms in a rural area of sub-Saharan Africa: an in-depth qualitative study in the Masindi district of Uganda. Prim Care Respir J (2013) 1.57
New horizons in early stage COPD--improving knowledge, detection and treatment. Respir Med (2011) 1.56
Functional coupling of capping and transcription of mRNA. Mol Cell (2002) 1.56
Cost-effectiveness of telephone or surgery asthma reviews: economic analysis of a randomised controlled trial. Br J Gen Pract (2005) 1.53
Professional and patient attitudes to using mobile phone technology to monitor asthma: questionnaire survey. Prim Care Respir J (2006) 1.52
Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med (2012) 1.52
The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J (2009) 1.51
Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med (2007) 1.51
Prescribing of asthma medication in primary care for children aged under 10. Prim Care Respir J (2010) 1.50
New deal from the World Trade Organisation. BMJ (2003) 1.49
Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol (2007) 1.49
The national montelukast survey. J Allergy Clin Immunol (2005) 1.47
Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis (2012) 1.47
Efficacy versus effectiveness trials: informing guidelines for asthma management. Curr Opin Allergy Clin Immunol (2013) 1.45
Functional status measurement in COPD: a review of available methods and their feasibility in primary care. Prim Care Respir J (2011) 1.45
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection. Arch Intern Med (2003) 1.44
Symptom-based questionnaire for differentiating COPD and asthma. Respiration (2005) 1.43
Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control. Prim Care Respir J (2012) 1.43
Mid Staffordshire should lead to a fundamental rethink of government policy. BMJ (2013) 1.41
How the secretary of state for health proposes to abolish the NHS in England. BMJ (2011) 1.40
GOLD COPD categories are not fit for purpose in primary care. Lancet Respir Med (2013) 1.37
Pro-con debate: Inhaled corticosteroids should not be prescribed in primary care to children under two years of age - the case for. Prim Care Respir J (2008) 1.37
Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics (2005) 1.36
Quality standards for real-world research. Focus on observational database studies of comparative effectiveness. Ann Am Thorac Soc (2014) 1.32
Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler. Int J Chron Obstruct Pulmon Dis (2009) 1.32
EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 - a summary. Prim Care Respir J (2008) 1.31
Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness. Curr Allergy Asthma Rep (2011) 1.28
Cognitive performance in patients with COPD. Respir Med (2004) 1.26
ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol (2006) 1.26
Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain (2012) 1.25
Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma. J Clin Oncol (2009) 1.25
Asthma out of control? A structured review of recent patient surveys. BMC Pulm Med (2006) 1.24
Questions for COPD diagnostic screening in a primary care setting. Respir Med (2005) 1.23
How the Health and Social Care Bill 2011 would end entitlement to comprehensive health care in England. Lancet (2012) 1.22
Current control and future risk in asthma management. Allergy Asthma Immunol Res (2011) 1.22
Choosing inhaler devices for people with asthma: current knowledge and outstanding research needs. Respir Med (2010) 1.20
Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg (2002) 1.20
Improving physical activity in COPD: towards a new paradigm. Respir Res (2013) 1.20
An exploratory, pragmatic, cluster randomised trial of practice nurse training in the use of asthma action plans. Prim Care Respir J (2007) 1.19
Chronic obstructive pulmonary disease. BMJ (2003) 1.17
British Society for Sexual Medicine guidelines on the management of erectile dysfunction. J Sex Med (2008) 1.14
High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. Cancer (2003) 1.13
Best cases from the AFIP: omental lymphangioma with small-bowel volvulus. Radiographics (2003) 1.13
A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol (2012) 1.13
Befriending carers of people with dementia: randomised controlled trial. BMJ (2008) 1.12
Health status in routine clinical practice: validity of the clinical COPD questionnaire at the individual patient level. Health Qual Life Outcomes (2010) 1.10
Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control. BMC Pulm Med (2009) 1.10
Efficacy and safety of tiotropium in COPD patients in primary care--the SPiRiva Usual CarE (SPRUCE) study. Respir Res (2007) 1.08
UNLOCK: Uncovering and Noting Long-term Outcomes in COPD to enhance knowledge. Prim Care Respir J (2010) 1.07
The prevalence of dysfunctional breathing in adults in the community with and without asthma. Prim Care Respir J (2005) 1.07
Comparing virtual consults to traditional consults using an electronic health record: an observational case-control study. BMC Med Inform Decis Mak (2012) 1.07
Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection. AIDS (2002) 1.05
A flawed Bill with a hidden purpose. Lancet (2012) 1.05
Extending choice in the NHS. BMJ (2002) 1.05
Can a GP be a generalist and a specialist? Stakeholders views on a respiratory General Practitioner with a special interest service in the UK. BMC Health Serv Res (2006) 1.04
Health and Social Care Bill 2011: a legal basis for charging and providing fewer health services to people in England. BMJ (2012) 1.04
From support to boundary: a qualitative study of the border between self-care and professional care. Patient Educ Couns (2009) 1.03
General practitioners with a special interest in respiratory medicine: national survey of UK primary care organisations. BMC Health Serv Res (2005) 1.02
Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone. J Allergy Clin Immunol (2013) 1.02
Incentives for organ donation: proposed standards for an internationally acceptable system. Am J Transplant (2011) 0.99
Poor communication may impair optimal asthma care: a qualitative study. Fam Pract (2006) 0.99
The use of a modification of the Patient Enablement Instrument in asthma. Prim Care Respir J (2007) 0.99